Dr. Man Dangar is a distinguished oncology specialist with deep expertise in CAR-T (Chimeric Antigen Receptor T-cell) cell therapy. With a commitment to transforming cancer care through innovation and compassion, Dr. Dangar focuses on advanced immunotherapies for treating complex and relapsed hematologic cancers, including leukemia and lymphoma.
He has played a key role in the clinical adoption and optimization of CAR-T therapy, working closely with leading hospitals and research institutions to bring personalized, cell-based treatments to the forefront of oncology. Dr. Dangar’s approach emphasizes precision medicine—tailoring therapies based on each patient’s unique genetic and clinical profile.
An advocate for continuous advancement in cancer treatment, Dr. Dangar regularly contributes to oncology research, publishes in respected medical journals, and shares insights at global conferences. His work reflects a vision of delivering hope and healing to patients facing the most challenging cancer diagnoses.
Leukemia (ALL, CLL)
Lymphoma (DLBCL, FL)
Multiple Myeloma
CAR-T Cell Therapy
Immuno-oncology
Personalized Cancer Treatment
MBBS – University of London
MD (Oncology) – GNU
Fellowship in Hematologic Oncology – birla
15
“Efficacy of CAR-T Cell Therapy in Relapsed Lymphoma Patients”, Journal of Clinical Oncology, 2023
“Managing CRS and ICANS in CAR-T Recipients”, Indian Oncology Review, 2022
Research Fellow – CAR-T Cell Therapy Unit
“Efficacy of CAR-T Cell Therapy in Relapsed Lymphoma Patients”, Journal of Clinical Oncology, 2023
“Managing CRS and ICANS in CAR-T Recipients”, Indian Oncology Review, 2022
The Excellence in Patient Care Award: Exceptional patient care, including quality of care, patient satisfaction, and patient safety.
The Innovations in Healthcare Award: Innovative approach to healthcare, including the use of advanced technologies and cutting-edge medical procedures.
The Patient Safety Award: Unwavering commitment to patient safety, including the use of rigorous safety protocols and procedures.
The Community Outreach Award: Dedication to improving the health and wellbeing of its local community through outreach programs and initiatives.
The Excellence in Patient Care Award: Exceptional patient care, including quality of care, patient satisfaction, and patient safety.
The Innovations in Healthcare Award: Innovative approach to healthcare, including the use of advanced technologies and cutting-edge medical procedures.
The Patient Safety Award: Unwavering commitment to patient safety, including the use of rigorous safety protocols and procedures.
The Community Outreach Award: Dedication to improving the health and wellbeing of its local community through outreach programs and initiatives.
© 2025 CAR T-Shell Therapy. All rights reserved.
Harnessing the power of your immune system to fight cancer—personalized, innovative, and life-changing treatment.
